Aug 19, 2026 · 6 min
Three corporate results put turnaround bets in focus
SK Hynix Rises, Moderna Gains, Estee Lauder Soars as Results Show Turnaround Gaining Steam
The episode shows how capital returns, clinical progress, and improving sales are driving sharply different kinds of investor enthusiasm.
- 1SK Hynix’s $29 billion buyback announcement sent its shares sharply higher.
- 2Moderna’s late-stage personalized melanoma vaccine results strengthened the case for mRNA-based cancer therapy.
- 3Estée Lauder ended a run of revenue declines with strong fiscal fourth-quarter results.
Don't miss
SK Hynix’s announcement of a $29 billion share buyback stands out as the episode’s largest and most immediate market catalyst.
The brief
Hosts Paul Sweeney and Kristine Aquino frame a market-movers discussion around three companies whose latest announcements changed the investment story.
SK Hynix surged after announcing a massive $29 billion share buyback, making shareholder returns the clearest immediate catalyst in the group.
Moderna’s promising late-stage results for a personalized melanoma vaccine put mRNA-based cancer therapy at the center of its market gain.
Estée Lauder broke a streak of revenue declines with strong fiscal fourth-quarter results, offering evidence that its turnaround may be gaining traction.
Together, the three cases show how markets reward distinct forms of progress: returning capital, advancing a therapy, and restoring sales momentum.
What was said on this episode
3 statements · 3 positive
SK Hynix’s buyback appears intended to restore investor confidence after its share decline.
“this seems like an effort to shore up or reshore up that investor confidence given that massive share decline”
Listen at 1:47
Moderna’s mRNA technology will achieve a successful post-COVID commercial phase.
“the technology that made Moderna household name during the COVID era will have a successful second act”
Listen at 2:46
Kristine Aquino recommends Estée Lauder’s Advanced Night Repair serum.
“the advanced night repair serum from Estee Lauder highly recommend”
Listen at 3:39
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
Stéphane Bancel
mRNA-based cancer therapy
The Estée Lauder Companies Inc.Listen to the full episode and explore every guest, topic, and moment on PodLume.